Key result
Angiotensin 1-7 (1 nM) reduced cell proliferation in DU-145 cells and decreased MKI67 expression in LNCaP cells, modulating molecular processes central to prostate cancer pathogenesis.
Why the study?
Does Angiotensin 1-7 modulate molecular and cellular processes in prostate cancer cells?
Does Angiotensin 1-7 modulate molecular and cellular processes in prostate cancer cells?
p-value: p=<0.05
Angiotensin 1-7 modulates cellular proliferation, gene expression, and hormonal receptor levels in prostate cancer cell lines, suggesting a complex role of the local renin-angiotensin system in prostate carcinogenesis.
No takes yet. Share an insight, caveat, or question.
Does not support clinical use in prostate cancer; leaves open therapeutic potential pending in vivo validation.
Domińska et al. (2018) studied Prostate cancer. Angiotensin 1-7 vs. Untreated cells was evaluated on Cell proliferation and viability (p=<0.05). Angiotensin 1-7 (1 nM) reduced cell proliferation in DU-145 cells and decreased MKI67 expression in LNCaP cells, modulating molecular processes central to prostate cancer pathogenesis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: